Skip to main content

ScholarsBetaWeill Cornell Medicine

Browse About Sign in

Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Loading search results…

Browse

Scholars8,803 Publications201,348 Funding7,268 Clinical research2

FiltersClear all

Status

Active, not recruiting1
Completed1

Study type

Interventional2

Phase

Phase 31
Not applicable1

Investigator

James E. Ip2

Department

Medicine2

Condition

Tachycardia, Ventricular2
Atrial Fibrillation19
Heart Failure15
Stroke8
Cardiovascular Diseases7

Intervention type

Device2
Drug3
Radiation1

Sponsor type

Other academic1
Industry1

Start date

to

Tachycardia, Ventricular×Device×Clear all

Showing 1–2 of 2 studiesSort:

Active, not recruitingInterventional · Not applicableNCT05855135 ↗
Assessment of the Safety and Efficacy of a Combined Cardiac Contractility Modulation and Implantable Cardioverter Defibrillator Device for Subjects With Heart Failure and Reduced Ejection Fraction

Show all 50

Show fewer

Intervention: Device: OPTIMIZER® Integra CCM-D System (Treatment Arm)
Dates: May 2023 – Dec 2025
Sponsor: Impulse Dynamics USA, Inc.

Heart FailureHeart Failure With Reduced Ejection FractionImplantable Defibrillator User+7 more

CompletedInterventional · Phase 3NCT04952610 ↗

An Open Label Extension Study of Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia

Intervention: Drug: Etripamil NS 70 mg · Device: Aptar Pharma Nasal Spray Bidose System
Dates: Dec 2021 – Apr 2026
Sponsor: Milestone Pharmaceuticals

Paroxysmal Supraventricular Tachycardia